SCHEMBL19638048

SCHEMBL19638048

N#Cc1sc(N)nc1-c1cc(Cl)cs1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MYC P01106 2/20 0.38
WDR5 P61964 2/20 0.38
MEN1 O00255 4/20 0.34
KMT2A Q03164 4/20 0.34
KDM4E B2RXH2 3/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2C9 P11712 2/20 0.34
USP2 O75604 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C19 P33261 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
TLR9 Q9NR96 1/20 0.34
ALDH1A1 P00352 4/20 0.32
CFTR P13569 1/20 0.32
MAPT P10636 3/20 0.31
ALOX15 P16050 2/20 0.31
HSD17B10 Q99714 2/20 0.31
ALOX12 P18054 1/20 0.31
HPGD P15428 2/20 0.31
ADORA2A P29274 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19966961 0.80 MEN1 (0.51) MYCWDR5MEN1KMT2AKDM4E
SCHEMBL19967217 0.76 MPL (0.41) KDM4ECYP3A4ALDH1A1CFTRMAPT
SCHEMBL19638019 0.72 MEN1 (0.61) MEN1KMT2AKDM4ECYP3A4CYP2C9
SCHEMBL954791 0.72 KDM4E (0.48) MYCWDR5KDM4EUSP2ALDH1A1
SCHEMBL1852794 0.72 ADORA1 (0.58) MYCWDR5MEN1KMT2AADORA2A
SCHEMBL29250760 0.72 PTGS1 (0.37) KDM4ECYP3A4ALDH1A1ALOX15HSD17B10
SCHEMBL23782480 0.70 KDM4E (0.55) MYCWDR5KDM4ECYP3A4ALDH1A1
SCHEMBL30173829 0.70 KDM4E (0.55) MYCWDR5KDM4ECYP3A4ALDH1A1
SCHEMBL31311334 0.70 MPL (0.47) MYCWDR5MEN1KMT2AKDM4E
SCHEMBL21170389 0.70 HTT (0.39) MEN1KMT2AALDH1A1CFTRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110198939-B Modulators of adenosine A3 receptors 帕罗生物制药有限公司 2023-03-28 CN disclosed
CN-107207445-B Adenosine A3Modulators of receptors 帕罗生物制药有限公司 2021-03-16 CN disclosed
EP-3581572-B1 ADENOSINE A3 RECEPTOR MODULATORS PALOBIOFARMA SL (ES) 2020-11-25 EP disclosed
US-10744125-B2 Adenosine A3 receptor modulators PALOBIOFARMA, S.L. (ES) 2020-08-18 US disclosed
EP-3248964-B1 THIAZOLE MODULATORS OF A3 ADENOSINE RECEPTORS PALOBIOFARMA SL (ES) 2019-07-17 EP disclosed
US-10238637-B2 Modulators of the adenosine A3 receptors PALOBIOFARMA, S.L. (ES) 2019-03-26 US disclosed
US-20180263963-A1 MODULATORS OF THE ADENOSINE A3 RECEPTORS PALOBIOFARMA, S.L. (ES) 2018-09-20 US disclosed
EP-3248964-A1 THIAZOLE MODULATORS OF A3 ADENOSINE RECEPTORS PALOBIOFARMA S.L. (ES) 2017-11-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180263963-A1 MODULATORS OF THE ADENOSINE A3 RECEPTORS ADORA3, ADORA2A, ADORA1 MYC 4788/4885WDR5 3585/4885MEN1 3374/4885
US-10744125-B2 Adenosine A3 receptor modulators ADORA3, ADORA2A, ADORA1 MYC 4695/4885WDR5 3622/4885MEN1 3716/4885
US-10238637-B2 Modulators of the adenosine A3 receptors ADORA3, ADORA2A, ADORA1 MYC 4788/4885WDR5 3585/4885MEN1 3374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.